Signatures of TOP1 transcription-associated mutagenesis in cancer and germline.
Reijns MAM., Parry DA., Williams TC., Nadeu F., Hindshaw RL., Rios Szwed DO., Nicholson MD., Carroll P., Boyle S., Royo R., Cornish AJ., Xiang H., Ridout K., Genomics England Research Consortium None., Colorectal Cancer Domain UK 100,000 Genomes Project None., Schuh A., Aden K., Palles C., Campo E., Stankovic T., Taylor MS., Jackson AP.
The mutational landscape is shaped by many processes. Genic regions are vulnerable to mutation but are preferentially protected by transcription-coupled repair1. In microorganisms, transcription has been demonstrated to be mutagenic2,3; however, the impact of transcription-associated mutagenesis remains to be established in higher eukaryotes4. Here we show that ID4-a cancer insertion-deletion (indel) mutation signature of unknown aetiology5 characterized by short (2 to 5 base pair) deletions -is due to a transcription-associated mutagenesis process. We demonstrate that defective ribonucleotide excision repair in mammals is associated with the ID4 signature, with mutations occurring at a TNT sequence motif, implicating topoisomerase 1 (TOP1) activity at sites of genome-embedded ribonucleotides as a mechanistic basis. Such TOP1-mediated deletions occur somatically in cancer, and the ID-TOP1 signature is also found in physiological settings, contributing to genic de novo indel mutations in the germline. Thus, although topoisomerases protect against genome instability by relieving topological stress6, their activity may also be an important source of mutations in the human genome.